BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8396067)

  • 1. Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.
    Santos A; Osorio-Almeida L; Baird PN; Silva JM; Boavida MG; Cowell J
    Hum Genet; 1993 Aug; 92(1):83-6. PubMed ID: 8396067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
    Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
    Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
    Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
    Pritchard-Jones K; Renshaw J; King-Underwood L
    Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
    Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
    Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new WT1 mutation in a sporadic Wilms' tumour.
    Santos AC; Boavida MG; Costa A; Osorio-Almeida L
    Biochim Biophys Acta; 1998 Aug; 1407(2):109-13. PubMed ID: 9685601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
    Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y; Yokomori K; Choi SH
    Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical mutation in both WT1 alleles is not sufficient to cause Wilms' tumor.
    Kikuchi H; Akasaka Y; Kurosawa Y; Yoneyama H; Kato S; Hata J
    FEBS Lett; 1995 Feb; 360(1):26-8. PubMed ID: 7875294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
    J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
    Baird PN; Pritchard J; Cowell JK
    Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.